FORM 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C. 20549


[x]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
        EXCHANGE ACT OF 1934

                For the Quarterly Period Ended January 31, 2006


                           Commission File Number: 0-10315


                            IMPLANTABLE VISION, INC.

             (Exact name of registrant as specified in its charter)

                     (Formerly Baymark Technologies, Inc.)


                 Utah                                          95-4091368
        (State or other jurisdiction of                      (I.R.S. Employer
        incorporation or organization)                       Identification No.)

25730 Lorain Road, North Olmsted, Ohio                      44070
----------------------------------                         --------
(Address of principal executive offices)                   (Zip Code)

Issuer's telephone number, including area code: (212)-835-6198

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2)  has  been  subject  to the  filing
requirements for at least the past 90 days.

              Yes X     No
               -----    -----

Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). Yes [__] No [X]

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date.


The  number of shares outstanding of  the issuer's common stock, par value $.001
per share, at January 31, 2005, was 30,372,200 shares.

<PAGE>
                            IMPLANTABLE VISION, INC.
                      (FORMERLY BAYMARK TECHNOLOGIES, INC.)
                                   (UNAUDITED)

                              FINANCIAL STATEMENTS

                        SIX MONTHS ENDED JANUARY 31, 2006

<PAGE>
JASPERS + HALL, PC
CERTIFIED PUBLIC ACCOUNTANTS
--------------------------------------------------------------------------------
9175 E. Kenyon Avenue, Suite 100
Denver, CO 80237
303-796-0099

             REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors
Inplantable Vision, Inc

We have reviewed the  accompanying  balance sheet for  Implantable  Vision,  Inc
(formerly  Baymark  Technologies,  Inc.) as of January  31, 2006 and the related
statements of  operations  for the three and  six-months  and cash flows for the
six-months then ended. These financial  statements are the responsibility of the
Company's management.

We conducted  our review in  accordance  with  standards  of the Public  Company
Accounting  Oversight  Board (United  States).  The review of interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with standards of the Public Company Accounting Oversight Board (United States),
the objective of which is the  expression of an opinion  regarding the financial
statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the  accompanying  financial  statements for them to be in conformity
with accounting principles generally accepted in the United States of America.




Jaspers + Hall, PC
March 15, 2006
Jaspers + Hall, PC

<PAGE>
<TABLE>
<CAPTION>

                            IMPLANTABLE VISION, INC.
                     (Formerly Baymark Technologies, Inc.)
                           Consolidated Balance Sheet

                                                                                            Unaudited          Audited
                                                                                           January 31,        July 31,
                                                                                              2006              2005
                                                                                          --------------    --------------
<S>                                                                                       <C>               <C>

ASSETS;
Current Assets:
    Cash                                                                                      $ 629,985               $ -
                                                                                          --------------    --------------

        Total Current Assets                                                                    629,985                 -
                                                                                          --------------    --------------

Fixed Assets:
     Property & Equipment                                                                        19,050           33,950
     Less Accumulated Depreciation                                                                    -          (33,950)
                                                                                          --------------    --------------

          Total Fixed Assets                                                                     19,050                -
                                                                                          --------------    --------------

TOTAL ASSETS                                                                                  $ 649,035              $ -
                                                                                          ==============    ==============


LIABILITIES & STOCKHOLDERS' EQUITY
Current Liabilities:
    Accounts Payable                                                                           $ 23,878          $298,944
    Accruals                                                                                      1,879           141,573
    Note Payable - Related Party                                                                      -           168,731
    Discontinued Operations Liability                                                                 -               148
                                                                                          --------------    --------------

        Total Current Liabilties                                                                 25,757           609,396
                                                                                          --------------    --------------

 Stockholders Equity:
    Preferred Stock, $.001 par value, 100,000,000 shares authorized                               1,000             1,000
       Series A Convertible preferred stock 1,000,000 shares
       issued and outstanding 2006 and 2005
       Series B Convertible preferred stock no shares                                                 -               100
       issued and outstanding 2006 and 2005
    Common stock, $.001 par value, 150,000,000 shares authorized                                 30,373             6,623
        30,372,200 shares of stock issued and outstanding January 2006
        662,200 shares issued and outstanding July 2005
     Stocks to be issued                                                                      1,227,875
    Additional Paid-In Capital                                                                7,818,921         7,812,361
    Accumulated deficit                                                                      (8,454,891)       (8,429,480)
                                                                                          --------------    --------------

        Total Stockholders' Equity                                                              623,278          (609,396)
                                                                                          --------------    --------------

TOTAL LIABILITIES & STOCKHOLDERS' EQUITY                                                      $ 649,035               $ -
                                                                                          ==============    ==============
</TABLE>
See Accountants Review Report

<PAGE>
<TABLE>
<CAPTION>

                            IMPLANTABLE VISION, INC.
                     (Formerly Baymark Technologies, Inc.)
                      Consolidated Statement of Operations

                                                             Three-Months Ended                    Six-Months Ended
                                                                  January 31,                          January 31,
                                                           2006              2005               2006              2005
                                                           ----              ----               ----              ----
<S>                                                      <C>                 <C>            <C>                 <C>

Revenue:
    Sales                                                      $ -             $ -                $ -               $ -
                                                         ----------          ---------      ----------          ---------
Total Income                                                     -               -                  -                 -
                                                         ----------          ---------      ----------          ---------
Operating Expenses:
     Administrative Expenses                                100,040              -             134,997                -
                                                         ----------          ---------      ----------          ---------
Total Expenses                                              100,040              -             134,997                -
                                                         ----------          ---------      ----------          ---------
Net Loss From Operations                                   (100,040)             -            (134,997)               -
                                                         ----------          ---------      ----------          ---------
Other Income/Expense
    Forgiveness of debt                                     134,396              -             134,396                -
    Acquisition Costs                                       (24,810)             -             (24,810)               -
                                                         ----------          ---------      ----------          ---------
Net Other Income/Expense                                    109,586              -             109,586            109,586
                                                         ----------          ---------      ----------          ---------
Net Gain/Loss                                            $    9,546            $ -           $ (25,411)             $ -
                                                         ==========          =========      ==========          =========
Per Share Information:

     Weighted average number
     of common shares outstanding                        20,645,533          6,596,004      10,762,472          6,596,004
                                                         ----------          ---------      ----------          ---------
Net Loss per common share                                         *             *                *                *
                                                         ==========          =========      ==========          =========
* Less than $.01

</TABLE>
See Accountants' Review Report

<PAGE>
<TABLE>
<CAPTION>


                            IMPLANTABLE VISION, INC.
                     (Formerly Baymark Technologies, Inc.)
                  Consolidated Stockholders' Equity (Deficit)
                       For Period Ended January 31, 2006


                                            PREFERRED STOCK                         COMMON STOCKS     Additional
                                         SERIES A               SERIES B                               Paid-In     Stock to be
                                    # of Shares   Amount   # of Shares Amount   # of Shares   Amount   Capital      Issued
                                    -----------   ------   ----------- ------   -----------   ------   -------      ------
<S>                                   <C>       <C>        <C>          <C>    <C>          <C>     <C>           <C>


Balance - July 31, 2004               100,000    $1,000     100,000     $ 100     662,200     $ 663 $ 7,818,321           $ -
                                      -------   -------    --------     -----  ----------   ------- -----------   -----------
Net Loss for Year                           -         -           -         -           -         -           -             -
                                      -------   -------    --------     -----  ----------   ------- -----------   -----------
Balance - July 31, 2005               100,000     1,000     100,000       100     662,200       663   7,818,321             -
                                      -------   -------    --------     -----  ----------   ------- -----------   -----------
Cancelled Stocks                            -         -    (100,000)     (100)   (300,000)     (300)        400             -
Capital Investment - Stock to
 Be Issued                                  -         -           -         -           -         -           -       475,000
Issuance of Stock to Directors              -         -           -         -      10,000        10           -             -
Issuance of Stock for Acquisition           -         -           -         -  30,000,000    30,000         200             -
Capital Investment - Stock to
 Be Issued                                  -         -           -         -           -         -           -       752,875
Net Loss for Period                         -         -           -         -           -         -           -
                                      -------   -------    --------     -----  ----------   ------- -----------   -----------
Balance - January 31, 2006            100,000   $ 1,000           -       $ -  30,372,200   $30,373 $ 7,818,921   $ 1,227,875
                                      =======   =======    ========     =====  ==========   ======= ===========   ===========
Stocks are shown with the 1 for 10
reverse split of stock in
September 2005

</TABLE>

See Accountants' Review Report

<PAGE>




                            IMPLANTABLE VISION, INC.
                     (Formerly Baymark Technologies, Inc.)
                  Consolidated Stockholders' Equity (Deficit)
                       For Period Ended January 31, 2006

(Continued)

              Total
Accumulated   Stockholders'
 Deficit      Equity
 -------      ------


Net Loss for Year                  $(8,429,480)   $ (609,396)
                                   -----------    ----------
Balance - July 31, 2005                      -             -
                                   -----------    ----------
Cancelled Stocks                    (8,429,480)     (609,396)
Capital Investment - Stock to      -----------    ----------
 Be Issued                                   -             -
Issuance of Stock to Directors               -       475,000
Issuance of Stock for Acquisition            -            10
Capital Investment - Stock to                -        30,200
 Be Issued                                   -       752,875
Net Loss for Period                    (25,411)      (25,411)
                                   ------------   ----------
Balance - January 31, 2006         $ (8,454,891)   $ 623,278
                                   ============   ==========
Stocks are shown with the 1 for 10
reverse split of stock in
September 2005

See Accountants' Review Report


<PAGE>
<TABLE>
<CAPTION>


                            IMPLANTABLE VISION, INC.
                     (Formerly Baymark Technologies, Inc.)
                      Consolidated Statement of Cash Flows

                                Indirect Method

                                                                                                           Six-Months Ended
                                                                                                             January 31,
                                                                                                       2006               2005
                                                                                                       ----               ----
<S>                                                                                                     <C>                <C>

Cash Flows from Operating Activities:

     Net (Loss)                                                                                         $ (25,411)            $ -
     Issuance of stock for services                                                                            10               -
     Adjustments to reconcile net loss to cash used
        by operating activities
     (Decrease) in Discontinued Operation Liability                                                          (148)              -
     (Decrease) in accounts payable and accrued expenses                                                 (414,760)              -
                                                                                                        ---------          ---------
Net Cash Used by Operating Activities                                                                    (440,309)              -
                                                                                                        ---------          ---------
Cash flows from Investing Activities:
     Sale of Property                                                                                     (33,950)              -
     Purchase of Property                                                                                  14,900               -
                                                                                                        ---------          ---------
Net Cash used for Investing Activities                                                                    (19,050)              -
                                                                                                        ---------          ---------
Cash Flows from Financing Activities:

     Acquisition of Subsidiary                                                                             30,200               -
     Capital Investment - Stocks to be issued                                                           1,227,875
     Payments to Loans from officers                                                                     (168,731)              -
                                                                                                        ---------          ---------
Net Cash Provided by Financing Activities                                                               1,089,344               -
                                                                                                        ---------          ---------
Net Increase in Cash & Cash Equivalents                                                                   629,985               -

Beginning Cash & Cash Equivalents                                                                               -               4
                                                                                                        ---------          ---------
Ending Cash & Cash Equivalents                                                                          $ 629,985             $ 4
                                                                                                        =========          =========

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
     Cash paid for Interest                                                                             $ -                $ -
                                                                                                        =========          =========
     Cash paid for Income Taxes                                                                         $ -                $ -
                                                                                                        =========          =========
NON-CASH TRANSACTIONS
     Common stock issued for services                                                                   $ 10               $ -
                                                                                                        =========          =========

</TABLE>
See Accountants' Review Report

<PAGE>

                            IMPLANTABLE VISION, INC.
                      (Formerly Baymark Technologies, Inc.)
                   Notes to Consolidated Financial Statements
                                January 31, 2006
                                   (Unaudited)


Note 1 - Organization and Summary of Significant Accounting Policies:
         ------------------------------------------------------------

Organization:

The  Company  (formerly   E-Commerce  West  Corp.),  a  Utah  Corporation,   was
incorporated on March 21, 1981.  Since  incorporation  the Company has undergone
several name,  ownership,  directional and management changes.  The consolidated
financial  statements  include  the  accounts  of  Baymark  Technologies,  Inc.,
Westerngold.com Corp, Atlantic Pacific Corp.  (Goldiggers),  Royal Casino Group,
Inc. and ISP Gold, Inc. All of the subsidiaries  have been  discontinued  except
for ISP Gold, Inc. in the year ended July 2001. On December 16, 2005 the Company
entered into an agreement and plan of Reorganization with JIG JIG, LLC (JIG) and
its interest holders.  JIG is merged into BT Acquisitions,  Inc., a newly formed
subsidiary of Baymark  Technologies,  Inc. In December 2005 the name was changed
to Implantable Vision, Inc.  Fiscal year end is July 31.

Basis of Accounting:
--------------------

The accompanying financial statements have been prepared on the accrual basis of
accounting in accordance with generally accepted accounting principles.

Cash and Cash Equivalents:
-------------------------

The Company  considers all highly  liquid debt  instruments,  purchased  with an
original maturity of three months or less, to be cash equivalents.

Use of Estimates:
----------------

The preparation of financial  statements,  in conformity with generally accepted
accounting  principles,  requires  management to make estimates and  assumptions
that affect the reported  amounts of assets and  liabilities,  and disclosure of
contingent  assets and  liabilities at the date of the financial  statements and
the reported amounts of revenue and expenses during the reporting period. Actual
results could differ from those estimates.

Net Loss Per Share:
------------------

Net loss per share is based on the  weighted  average  number  of common  shares
outstanding during the period.

Property and Equipment
----------------------

Equipment  and property are  capitalized  at  acquisition  cost and  depreciated
utilizing the straight-line  method over its estimated useful life.  Maintenance
and repairs are charged to operations as incurred.

Other Comprehensive Income
--------------------------

The Company has no material components of other comprehensive income (loss), and
accordingly, net loss is equal to comprehensive loss in all periods.

<PAGE>



                            IMPLANTABLE VISION, INC.
                      (Formerly Baymark Technologies, Inc.)
                   Notes to Consolidated Financial Statements
                                January 31, 2006
                                   (Unaudited)


Note 2- Capital Stock Transactions:
----------------------------------

The  authorized  capital  stock of the Company is  150,000,000  shares of common
stock at $.001 par value and 100,000,000  shares of preferred stock at $.001 par
value. In September 2005 the Company  authorized a 1 for 10 reverse split of all
common stock and cancelled  the Preferred B shares of stock.  All shares and per
share amounts in the accompanying  financial statements of the Company and notes
thereto  have been  retroactively  adjusted  to give the  effects of the reverse
stock split.  The Company has issued an additional  29,710,000  shares of common
stock in the six months  ended  January  2006 and raised  additional  capital of
$1,227,875 for shares of stock to be issued in a Private Placement. 300,000
shares of common stock were retired to treasury in the period.


<PAGE>


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

Cautionary and Forward Looking Statements


     In addition to  statements of historical  fact,  this Form 10-QSB  contains
forward-looking  statements.  The  presentation of future aspects of Implantable
Vision, Inc. , ("Implantable  Vision,  Inc." the "Company" or "issuer") found in
these  statements is subject to a number of risks and  uncertainties  that could
cause  actual  results  to  differ  materially  from  those  reflected  in  such
statements.  Readers  are  cautioned  not  to  place  undue  reliance  on  these
forward-looking  statements,  which reflect management's analysis only as of the
date hereof.  Without  limiting the generality of the  foregoing,  words such as
"may," "will," "expect,"  "believe,"  "anticipate,"  "intend," or "could" or the
negative  variations thereof or comparable  terminology are intended to identify
forward-looking statements.

     These forward-looking statements are subject to numerous assumptions, risks
and uncertainties that may cause Implantable  Vision,  Inc. actual results to be
materially different from any future results expressed or implied by Implantable
Vision, Inc. in those statements. Important facts that could prevent Implantable
Vision,  Inc. from achieving any stated goals  include,  but are not limited to,
the following:

         Some of these risks might include, but are not limited to, the
following:

                  (a)      volatility or decline of the Company's stock price;

                  (b)      potential fluctuation in quarterly results;

                  (c)      failure of the Company to earn revenues or profits;

                  (d)      inadequate capital to continue or expand its busi-
                           ness, inability to raise additional capital or financ
                           -ing to implement its business plans;

                  (e)      failure to achieve any business.

                  (f)      rapid and significant changes in markets;

                  (g)      litigation with or legal claims and allegations by
                           outside parties;

                  (h)      insufficient revenues to cover operating costs.




<PAGE>

         There is no assurance that the Company will be profitable, the Company
may not be able to successfully develop, manage or market its products and
services, the Company may not be able to attract or retain qualified executives
and technology personnel, the Company's products and services may become
obsolete, government regulation may hinder the Company's business, additional
dilution in outstanding stock ownership may be incurred due to the issuance of
more shares, warrants and stock options, or the exercise of warrants and stock
options, and other risks inherent in the Company's businesses.

The Company  undertakes no obligation to publicly  revise these  forward-looking
statements to reflect events or circumstances  that arise after the date hereof.
Readers should  carefully  review the factors  described in other  documents the
Company  files from time to time with the  Securities  and Exchange  Commission,
including the Quarterly  Reports on Form 10-QSB and Annual Report on Form 10-KSB
filed by the Company for fiscal year ended July 31, 2005 and any Current Reports
on Form 8-K filed by the Company.

Changes in Financial Condition

The Company  completed its reverse  acquisition in December 2005 of Jig Jig, LLC
and  changed  its  name  to  Implantable  Vision,  Inc.  The  operations  of the
reorganized/recapitalized company are those of the on going business. As part of
the  reorganization  $414,760 in accounts payable were eliminated and $1,227,875
from capital and a private  placement of stock was  received.  This resulted in
the company having $629,000 approximately, on hand at the end of the quarter.


RESULTS OF OPERATIONS FOR THE QUARTER ENDED JANUARY 31, 2006 COMPARED TO THE
SAME PERIOD IN 2005.

During the quarters ended January 31, 2006, and 2005, no operating revenues were
generated. The Company had no other operating income during the quarter.

The company had  administrative  expenses in the quarter in 2006 of $100,040 and
none in 2005.  The company  incurred no operating  expenses in 2006 and 2005, in
the  quarter.  The  net operating loss was  ($100,040)  in the  quarter in 2006
compared to none in the quarter in 2005.

In the period ended January 31, 2006 the Company settled its outstanding
payables and recorded $134,396 in forgiveness of debt as other income and
incurred acquisition costs of $24,810 for net other income of $109,586.

The net gain for the period in 2006 was $9,546 after other income/expense.

The profit/loss per share was nominal in the quarter in 2006 and none in 2005.

The Company expects the trend of operating losses to continue into the future at
an increasing rate, until the company achieves sales of which there is no
assurance.



<PAGE>

RESULTS OF OPERATIONS FOR THE SIX MONTH PERIOD ENDED JANUARY 31, 2006

The Company  experienced a total of $134,997 in  administrative  expenses in the
six month period ended January 31, 2006 as compared with none in the same period
a year earlier.  The Company had no operating  expenses in the period in 2006 or
2005.  The Company  incurred a net operating loss of ($134,997) in the period in
2006 compared to no loss in the period in 2005.

In the period ended January 31, 2006 the Company settled its outstanding
payables and recorded $134,396 in forgiveness of debt as other income and
incurred acquisition costs of $24,810 for net other income of $109,586.

The net loss for the period in 2006 was ($25,411) after other income/expense,
compared to none in the same period a year earlier.

The profit/loss per share was nominal in the six months ended January 31, 2006,
compared to none in the same period in 2005.

The Company expects the trend of operating losses to continue into the future at
an increasing rate, until the company achieves sales of which there is no
assurance.

LIQUIDITY AND CAPITAL RESOURCES

     Year to date,  the  company  had no  revenue,  but has  increased  its cash
position to $629,000  approximately.  The company had no other assets of any
value at period end.

     The  company's  only capital  resources are its common stock which might be
sold to raise capital.

NEED FOR ADDITIONAL FINANCING

     The Company has  capital  sufficient  to meet the  Company's  current  cash
needs,   including  the  costs  of  compliance  with  the  continuing  reporting
requirements of the Securities Exchange Act of 1934. The Company will seek loans
or equity  placements  to cover future cash needs.  Lack of its capital may be a
sufficient impediment to prevent it from accomplishing the goal of expanding its
operations.

     The Company will need to raise  additional  funds to carry out its business
activities in the next twelve months.

<PAGE>

         No commitments to provide additional funds have been made by management
or  other  stockholders.  Accordingly,  there  can  be  no  assurance  that  any
additional  funds  will be  available  to the  Company  to allow it to cover its
expenses as they may be incurred.

         Irrespective   of  whether  the  Company's  cash  assets  prove  to  be
inadequate to meet the Company's  operational  needs,  the Company might seek to
compensate providers of services by issuances of stock in lieu of cash.

GOING CONCERN

     The Company's auditor has issued a "going concern" qualification as part of
his opinion in the Audit Report. There is substantial doubt about the ability of
the Company to continue as a "going concern." The Company has no revenue stream,
limited  capital,  but cash of over  $629,000,  minimal  other  assets,  ongoing
expenses, and no capital commitments. The effects of such conditions could cause
the Company's insolvency, if a revenue stream is not developed.

     Management  hopes  to  seek  and  obtain  funding,  via  loans  or  private
placements  of stock  for  operations,  debt  and to  provide  working  capital.
Management  has  plans to seek  capital  in the  form of loans or stock  private
placements of approximately $1,500,000.

ITEM 3.  CONTROLS AND PROCEDURES

a.       Evaluation of Disclosure Controls and Procedures:

Disclosure  controls  and  procedures  are  designed to ensure that  information
required to be  disclosed in the reports  filed or submitted  under the Exchange
Act is recorded,  processed,  summarized  and  reported,  within the time period
specified  in the SEC's  rules and forms.  Disclosure  controls  and  procedures
include,  without  limitation,  controls and procedures  designed to ensure that
information required to be disclosed in the reports filed under the Exchange Act
is accumulated  and  communicated  to management,  including the Chief Executive
Officer and Chief Financial Officer,  as appropriate,  to allow timely decisions
regarding  required  disclosure.  As of the end of the  period  covered  by this
report  January 31,  2006,  the Company  carried  out an  evaluation,  under the
supervision and with the  participation of the Company's  management,  including
the  Company's  Chief  Executive  Officer and Chief  Financial  Officer,  of the
effectiveness of the design and operation of the Company's  disclosure  controls
and  procedures.  Based  upon and as of the date of that  evaluation,  the Chief
Executive  Officer and Chief  Financial  Officer  concluded  that the  Company's
disclosure  controls and  procedures  are  effective to ensure that  information
required to be disclosed in the reports the Company  files and submits under the
Exchange  Act is  recorded,  processed,  summarized  and  reported  as and  when
required.

b.       Changes in Internal Control over Financial Reporting:

There were no changes in the Company's internal control over financial reporting
identified in connection with the Company evaluation of these controls as of the
end of the period covered by this report that could have significantly affected
those controls subsequent to the date of the evaluation referred to in the
previous paragraph, including any correction action with regard to significant
deficiencies and material weakness.

<PAGE>


PART II.  OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

        NONE

ITEM  2. CHANGES IN SECURITIES

        NONE

ITEM  3. DEFAULTS UPON SENIOR SECURITIES

        NONE

ITEM  4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDER

        NONE

ITEM  5.  OTHER INFORMATION

        During the quarter the Company sold 632,668 shares of common stock @
$1.19/share.  Such shares had not yet been issued at January 31, 2006.  The
shares were sold in reliance upon Section 4 (6) of the Securities Act of 1933.

ITEM  6. EXHIBITS AND REPORTS ON FORM 8-K

        (a)     32    906 Sarbanes-Oxley Certification
                31    302 Sarbanes-Oxley Certification

        (b)     Reports on Form 8-K.

                Filed December 15, 2005
                Filed January 25, 2006
<PAGE>

  SIGNATURES

In  accordance  with section 13 of the Exchange  Act,  the  registrant  has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


George Rozakis                             March 21, 2005
- - --------------------------------------------------------
George Rozakis                             President